Tirzepatide is a dual GIP and GLP-1 receptor agonist research peptide studied for its role in incretin signaling, metabolic research, appetite-related pathways, and glucose-regulation models. It is of interest in research involving multi-pathway metabolic signaling.
Potential Research Benefits
- Blood-glucose regulation
- A1C reduction in type 2 diabetes research
- Insulin-sensitivity pathways
- Appetite and satiety signaling
- Body-weight reduction research
- Weight-maintenance research
- Reduced food intake/craving-related pathways
- Blood-pressure marker research
- Lipid and cholesterol marker research
- Fasting glucose and fasting insulin research
- Obesity-related inflammation pathways
- Fat-mass reduction research
- Metabolic-syndrome research
- Type 2 diabetes risk-reduction research
- Obstructive sleep apnea research in adults with obesity
- Liver-fat and fatty-liver/metabolic-dysfunction research
For laboratory and research use only. Not for human consumption.
This product is a research chemical. It is not a drug, food or cosmetic, and it is not for human or veterinary use. It is sold exclusively to qualified researchers and licensed laboratories.
This product has not been evaluated or approved by the U.S. Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease.
